Up­dat­ed: FDA pan­el backs Pfiz­er's RSV ma­ter­nal vac­cine, de­spite de­bate over safe­ty

An FDA in­de­pen­dent ad­vi­so­ry pan­el of in­fec­tious-dis­ease and vac­cine ex­perts vot­ed in gen­er­al sup­port of rec­om­mend­ing Pfiz­er’s RSV vac­cine, Abrys­vo, to pro­tect in­fants from the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER